iOrganBio
PrivateLast Round
Seed
Oct 29, 2025
Total Funding Raised
$2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
iOrganBio operates in Healthcare & Life Sciences and is based in Chapel Hill, North Carolina. Its latest recorded funding round was a Seed round in October 2025.
iOrganBio is a biotechnology company that provides an AI-powered platform called CellForge for the intelligent manufacturing of cells and organoids to accelerate disease modeling, regenerative medicine, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iOrganBio Comparables
Compare iOrganBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ChemT Biotechnology | 86% | |
| Cellino | 81% | |
| BioCurie | 81% |
For institutional investors. Book with your work email.
iOrganBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iOrganBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Terasaki Institute for Biomedical Innovation | Seed |
| Alix Ventures | Seed |
| 2ndF | Seed |
| First Star Ventures | Seed |
| IndieBio | Seed |
| Cape Fear BioCapital | Seed |
| SOSV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 16% QoQ, from 19 to 22 employees.
- Jul 17, 2026
Grew 25% QoQ, from 16 to 20 employees.
For institutional investors. Book with your work email.
iOrganBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iOrganBio's valuation, stock price, and market status.
Is iOrganBio a public or private company?
iOrganBio is a private company.
What is the current stock price of iOrganBio?
iOrganBio is a private company, so its shares have no public market price. Caplight tracks iOrganBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iOrganBio worth (valuation)?
Valuation information for iOrganBio is not publicly available.
Can I buy iOrganBio stock?
iOrganBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iOrganBio's last funding round?
iOrganBio's most recent funding round was Seed on October 29, 2025.
Who are the main investors in iOrganBio?
Key investors in iOrganBio include First Star Ventures.
Will iOrganBio IPO soon?
No public IPO plans have been announced for iOrganBio.
How can I track iOrganBio secondary market activity?
Caplight tracks bids, offers, and trades in iOrganBio's shares on secondary markets.